Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.

Antimicrobial agents and chemotherapy - 1 Feb 2013

Leang Rithea, Barrette Amy, Bouth Denis Mey, Menard Didier, Abdur Rashid, Duong Socheat, Ringwald Pascal

Abstract excerpt

We describe here the results of antimalarial therapeutic efficacy studies conducted in Cambodia from 2008 to 2010. A total of 15 studies in four sentinel sites were conducted using dihydroartemisinin-piperaquine (DP) for the treatment of Plasmodium falciparum infection and chloroquine (CQ) and DP for the treatment of P. vivax infection. All studies were performed according to the standard World Health...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Artemisinins
Share to Cambodia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chloroquine

Share to Malaria, Vivax

Share to Mefloquine

Share to Parasitic Sensitivity Tests

Share to Plasmodium vivax

Share to Quinolines

Source

Open in PubMed Open full text

Identifiers

PMID: 23208711
DOI: 10.1128/AAC.00686-12
PMCID: PMC3553743

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.PMID 23208711Read ↗

Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.Semantic proximity Read ↗

Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia.Semantic proximity Read ↗

Clinical and In Vitro Resistance of Plasmodium falciparum to Artesunate-Amodiaquine in CambodiaSemantic proximity Read ↗

Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine ResistanceSemantic proximity Read ↗

Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia.Semantic proximity Read ↗

Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterizationSemantic proximity Read ↗

Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization.Semantic proximity Read ↗

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam.Semantic proximity Read ↗

Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009.Semantic proximity Read ↗

Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia.Semantic proximity Read ↗

Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007.Semantic proximity Read ↗

Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and AfricaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.